瑛泰医疗拟收购目标公司至少51%控股权

财中社2024-12-18

财中社12月18日电瑛泰医疗（01501）发布公告，宣布与杭州唯强医疗科技有限公司及其他目标集团公司签订了收购意向协议。根据该协议，公司有条件同意通过增资和向目标公司的若干股东收购股权的方式，收购目标公司至少51%的控股权。此次交易的最终代价及完成形式将待后续正式收购协议确定。根据收购意向协议，公司计划向目标公司增资不少于2亿元，并预计在增资后持有目标公司至少51%的股权。此外，公司或其指定第三方...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492186146?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-18 21:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492186146","market":"hk","top_or_hot":-1,"title":"瑛泰医疗拟收购目标公司至少51%控股权","media":"财中社","content":"<div>\n<p>财中社12月18日电瑛泰医疗（01501）发布公告，宣布与杭州唯强医疗科技有限公司及其他目标集团公司签订了收购意向协议。根据该协议，公司有条件同意通过增资和向目标公司的若干股东收购股权的方式，收购目标公司至少51%的控股权。此次交易的最终代价及完成形式将待后续正式收购协议确定。根据收购意向协议，公司计划向目标公司增资不少于2亿元，并预计在增资后持有目标公司至少51%的股权。此外，公司或其指定第三方...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218212705ab81e857&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑛泰医疗拟收购目标公司至少51%控股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑛泰医疗拟收购目标公司至少51%控股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 21:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218212705ab81e857&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社12月18日电瑛泰医疗（01501）发布公告，宣布与杭州唯强医疗科技有限公司及其他目标集团公司签订了收购意向协议。根据该协议，公司有条件同意通过增资和向目标公司的若干股东收购股权的方式，收购目标公司至少51%的控股权。此次交易的最终代价及完成形式将待后续正式收购协议确定。根据收购意向协议，公司计划向目标公司增资不少于2亿元，并预计在增资后持有目标公司至少51%的股权。此外，公司或其指定第三方...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218212705ab81e857&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01501","symbol_name":"瑛泰医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218212705ab81e857&s=b","article_id":"2492186146","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218212705ab81e857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492186146","pubTimestamp":1734527439,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财中社12月18日电瑛泰医疗 发布公告，宣布与杭州唯强医疗科技有限公司及其他目标集团公司签订了收购意向协议。根据该协议，公司有条件同意通过增资和向目标公司的若干股东收购股权的方式，收购目标公司至少51%的控股权。目标公司主要从事主动脉及外周血管介入医疗器械的研究、开发、制造及销售，此次收购将进一步完善公司在该领域的产品布局。文章来源：财中社瑛泰医疗拟收购目标公司至少51%控股权","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01501":"瑛泰医疗","BK1222":"医疗保健用品"},"translate_title":"Yingtai Medical plans to acquire at least 51% controlling stake in target company","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01501":1},"content_text":"财中社12月18日电瑛泰医疗（01501）发布公告，宣布与杭州唯强医疗科技有限公司及其他目标集团公司签订了收购意向协议。根据该协议，公司有条件同意通过增资和向目标公司的若干股东收购股权的方式，收购目标公司至少51%的控股权。此次交易的最终代价及完成形式将待后续正式收购协议确定。根据收购意向协议，公司计划向目标公司增资不少于2亿元，并预计在增资后持有目标公司至少51%的股权。此外，公司或其指定第三方需在协议生效后支付预付款3000万元，该预付款将在正式收购协议中用于支付部分代价。目标公司主要从事主动脉及外周血管介入医疗器械的研究、开发、制造及销售，此次收购将进一步完善公司在该领域的产品布局。文章来源：财中社原标题：瑛泰医疗拟收购目标公司至少51%控股权","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492186146","isCrawlerRequest":true}